Cell plasticity and heterogeneity in cancer

Area of Science:

• Oncology
• Cancer Biology
• Cellular Plasticity

Background:

• Tumor heterogeneity arises from diverse cell types and cancer cell differences.
• Two models explain cancer progression: clonal evolution and cancer stem cell (CSC) hierarchy.
• The CSC model posits a unidirectional hierarchy, with CSCs driving tumor initiation and metastasis.

Purpose of the Study:

• To explore the evolving understanding of cancer development and progression.
• To investigate the concept of plasticity within cancer cell populations.
• To discuss the implications of non-CSC-to-CSC conversions for therapeutic strategies.

Main Methods:

• Review of existing literature on cancer evolution and stem cell models.
• Analysis of evidence supporting cellular plasticity in tumorigenesis.
• Discussion of the functional consequences of non-CSC-to-CSC conversions.

Main Results:

• Evolving evidence indicates significant plasticity between non-cancer stem cell (non-CSC) and CSC compartments.
• Non-CSCs can acquire a CSC phenotype, challenging the traditional unidirectional CSC model.
• Tumors may exhibit a plastic CSC model with bidirectional cell conversions.

Conclusions:

• Accumulating evidence suggests that aggressive CSCs can arise de novo within a tumor.
• Non-CSC-to-CSC conversions challenge current therapeutic strategies targeting CSCs.
• Understanding cellular plasticity is crucial for developing effective future cancer therapies.